The S&P 500 will trade in a range that implies the index dropping as much as 8% or rising a little over 1% in the coming ...

Pharmaceuticals stock, reducing the price target from $1,185.00 to $1,150.00. Despite the decrease, the firm maintained its Overweight rating on the NASDAQ-listed company. According to InvestingPro ...

The Fed made the right call in hitting pause this week. "I'm not sure that pausing is really all the bad for stocks in the ...

Fresh off of his stellar year in 2024, Dennis Lynch is Business Insider's Investor of the Month for January.

Morgan Stanley (NYSE:MS) upgraded Syensqo SA (SYENS:BB) stock from Underweight to Overweight, significantly raising the price target from EUR66.00 to EUR89.00. The revision reflects the firm's ...

Morgan Stanley Wealth Management (MSWM) is seeing a stall in the S&P 500 ( SP500 ), and said the Federal Reserve halting its ...

The bank tends to do well when there is volatility but a rising market, and we saw that in ... the dividend is a reason to own Morgan Stanley stock The bank has continued to raise its dividend ...

Narrow-moat-rated Morgan Stanley reported strong 2024 results, and we expect results to remain fairly strong for the foreseeable future. However, we believe the market has priced in this view over ...

This outlook is supported by ... As the financial services industry evolves, Morgan Stanley's ability to adapt to changing market conditions and client needs will be crucial in determining its ...

Investing.com -- Morgan Stanley raised its price target for Cheniere ... we do not believe the stock should reflect value for pre-final investment decision growth prospects until there is a ...

We recently compiled a list of the Morgan Stanley’s 15 Best European AI Stocks. In this article, we are going to take a look ...

according to Morgan Stanley's top stock strategist. Mike Wilson, the chief investment officer at the bank, said he believed rates were already hovering in the perfect range for stocks. Rates in ...